» Articles » PMID: 30057672

Curcumin Effectively Rescued Parkinson's Disease-Like Phenotypes in a Novel Model with DUCH Knockdown

Overview
Publisher Wiley
Date 2018 Jul 31
PMID 30057672
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between oxidative stress and neurodegenerative diseases has been extensively examined, and antioxidants are considered to be a promising approach for decelerating disease progression. Parkinson's disease (PD) is a common neurodegenerative disorder and affects 1% of the population over 60 years of age. A complex combination of genetic and environmental factors contributes to the pathogenesis of PD. However, since the onset mechanisms of PD have not yet been elucidated in detail, difficulties are associated with developing effective treatments. Curcumin has been reported to have neuroprotective properties in PD models induced by neurotoxins or genetic factors such as , , , and . In the present study, we investigated the effects of curcumin in a novel model of PD with knockdown of dUCH, a homolog of human UCH-L1. We found that dopaminergic neuron-specific knockdown of dUCH caused impaired movement and the loss of dopaminergic neurons. Furthermore, the knockdown of dUCH induced oxidative stress while curcumin decreased the ROS level induced by this knockdown. In addition, dUCH knockdown flies treated with curcumin had improved locomotive abilities and less severe neurodegeneration. Taken together, with studies on other PD models, these results strongly suggest that treatments with curcumin are an appropriate therapy for PD related to oxidative stress.

Citing Articles

Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases.

Guo F, Qin X, Mao J, Xu Y, Xie J Molecules. 2024; 29(23.

PMID: 39683859 PMC: 11643850. DOI: 10.3390/molecules29235700.


Senolytic and senomorphic secondary metabolites as therapeutic agents in models of Parkinson's disease.

Miller S, Darji R, Walaieh S, Lewis J, Logan R Front Neurol. 2023; 14:1271941.

PMID: 37840914 PMC: 10568035. DOI: 10.3389/fneur.2023.1271941.


Assessing Curcumin Uptake and Clearance and Their Influence on Superoxide Dismutase Activity in .

Hoffman T, Emsley S, Douglas J, Reed K, Esquivel A, Koyack M BioTech (Basel). 2023; 12(3).

PMID: 37754202 PMC: 10526445. DOI: 10.3390/biotech12030058.


Research Progress of Protein-Based Bioactive Substance Nanoparticles.

Han M, Liu K, Liu X, Rashid M, Zhang H, Wang M Foods. 2023; 12(16).

PMID: 37627998 PMC: 10453113. DOI: 10.3390/foods12162999.


Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids.

Cai B, Zhong L, Wang Q, Xu W, Li X, Chen T Front Pharmacol. 2023; 14:1198335.

PMID: 37388445 PMC: 10303117. DOI: 10.3389/fphar.2023.1198335.


References
1.
Bishop P, Rocca D, Henley J . Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J. 2016; 473(16):2453-62. PMC: 4980807. DOI: 10.1042/BCJ20160082. View

2.
Skibinski G, Finkbeiner S . Drug discovery in Parkinson's disease-Update and developments in the use of cellular models. Int J High Throughput Screen. 2013; 2011(2):15-25. PMC: 3596173. DOI: 10.2147/IJHTS.S8681. View

3.
Zhao X, Zhang L, Yu H, Sun Z, Lin X, Tan C . Curcumin protects mouse neuroblastoma Neuro-2A cells against hydrogen-peroxide-induced oxidative stress. Food Chem. 2019; 129(2):387-394. DOI: 10.1016/j.foodchem.2011.04.089. View

4.
Van der Merwe C, van Dyk H, Engelbrecht L, van der Westhuizen F, Kinnear C, Loos B . Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death. Mol Neurobiol. 2016; 54(4):2752-2762. DOI: 10.1007/s12035-016-9843-0. View

5.
Nass R, Merchant K, Ryan T . Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need. Mol Interv. 2009; 8(6):284-93. DOI: 10.1124/mi.8.6.6. View